New Class of Antiepileptic Drugs

New Class of Antiepileptic Drugs

Bookmark and Share


Epilepsy is a chronic neurological disorder characterized by recurrent seizures. These seizures are extremely debilitating and in some patients occur multiple times a day. Unfortunately, while numerous treatments for epilepsy have been developed, 25-30% of epilepsy patients do not achieve complete control of their seizures or are left suffering from severe side effects from their antiepileptic drugs. This leaves a large portion of the population without adequate treatment and a great need for the development of new treatments to help these patients.

Drs. Patrice L. Jackson-Ayotunde and Harper Tawes at the University of Maryland Eastern Shore have identified a new class of chemicals that possess antiepileptic properties in animal models. Through structural-activity relationship studies, they have developed twelve lead compounds that show antiepileptic properties in multiple animal models with limited to no observed neurotoxicity.

In 2013, the Office of Technology Commercialization (OTC) received 154 invention disclosures from the university’s renowned faculty. Ten of these inventions were selected as finalists for the Invention of the Year Award, based on their impact on science, society, and market potential. Winners will be announced on April 29, 2014 at the Celebration of Innovation and Partnerships event.

About OTC: The University of Maryland created OTC in 1986 to provide expert guidance, support, and assistance in safeguarding intellectual property, encouraging research, facilitating technological transfer, and promoting collaborative research and development agreements with industrial sponsors. Visit their website for more information.

April 25, 2014


Prev   Next

Current Headlines

UMD Expands Innovation and Commercialization Team

University of Maryland, Governor Hogan Announce Grant to Support the Development of a New Maryland Crime Research and Innovation Center

UMD Division of Research Announces Summer 2018 Tier 1 Award Winners

UMD Researchers Awarded $1.5 Million NSF Grant to Bridge Gap between Microelectronics, Biological Systems

UMD Assistant Professor Awarded $1.1 Million to Mitigate Rising Sea-level and Saltwater Intrusion along Maryland Eastern Shore

Detection of Single 'Ghost Particle' Yields Solution of Decade-Old Cosmic Ray Mystery

Semiconductor Quantum Transistor Opens Door for Photon-Based Computing

To Nap or Not? UMD Researcher Studies Impact of Sleep on Memory in Pre-Schoolers

News Resources

Return to Newsroom

Search News

Archived News

Events Resources

Events Calendar

Additional Resources

UM Newsdesk

Faculty Experts

Connect

social iconsFacebookTwitterLinkedInResearch News RSS Feed
Office of Technology Commercialization
2130 Mitchell Building
7999 Regents Dr.
University of Maryland
College Park, MD 20742

Phone: 301-405-3947  |  Fax: 301-314-9502
Email: umdtechtransfer@umd.edu

© Copyright 2013 University of Maryland

Did You Know

UMD's Neutral Buoyancy Research Facility, which simulates weightlessness, is one of only two such facilities in the U.S.